{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T15:01:12Z","timestamp":1749999672975,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Nature Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["No.23JRRA0939"],"award-info":[{"award-number":["No.23JRRA0939"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Innovation and Development Project of Lanzhou University","award":["lzuyxcx-2022-184"],"award-info":[{"award-number":["lzuyxcx-2022-184"]}]},{"DOI":"10.13039\/501100017702","name":"Innovation and Entrepreneurship Talent Project of Lanzhou","doi-asserted-by":"publisher","award":["2019-RC-33"],"award-info":[{"award-number":["2019-RC-33"]}],"id":[{"id":"10.13039\/501100017702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78932-z","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:27:37Z","timestamp":1731544057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of thyroid cancer on the survival of patients with digestive system tumors using SEER database"],"prefix":"10.1038","volume":"14","author":[{"given":"Siqin","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"78932_CR1","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1186\/s12889-023-17275-2","volume":"23","author":"X Li","year":"2023","unstructured":"Li, X. et al. Abdominal obesity and digestive system cancer: A systematic review and meta-analysis of prospective studies. BMC Public. Health. 23, 2343. https:\/\/doi.org\/10.1186\/s12889-023-17275-2 (2023).","journal-title":"BMC Public. Health"},{"key":"78932_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"78932_CR3","doi-asserted-by":"publisher","first-page":"13887","DOI":"10.1038\/s41598-022-17729-4","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu, H., Heng, X., Tian, Y. & Yang, Z. M. Effect of prior thyroid cancer on survival of primary liver cancer: A study based on the SEER database. Sci. Rep. 12, 13887. https:\/\/doi.org\/10.1038\/s41598-022-17729-4 (2022).","journal-title":"Sci. Rep."},{"key":"78932_CR4","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.3748\/wjg.v28.i41.5982","volume":"28","author":"XB Yang","year":"2022","unstructured":"Yang, X. B. et al. High incidence combination of multiple primary malignant tumors of the digestive system. World J. Gastroenterol. 28, 5982\u20135992. https:\/\/doi.org\/10.3748\/wjg.v28.i41.5982 (2022).","journal-title":"World J. Gastroenterol."},{"key":"78932_CR5","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2020.23130","volume":"324","author":"H Sung","year":"2020","unstructured":"Sung, H., Hyun, N., Leach, C. R., Yabroff, K. R. & Jemal, A. Association of First Primary Cancer with risk of subsequent primary Cancer among survivors of adult-onset cancers in the United States. Jama. 324, 2521\u20132535. https:\/\/doi.org\/10.1001\/jama.2020.23130 (2020).","journal-title":"Jama"},{"key":"78932_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00384-022-04105-x","volume":"37","author":"D Robertson","year":"2022","unstructured":"Robertson, D., Ng, S. K., Baade, P. D. & Lam, A. K. Risk of extracolonic second primary cancers following a primary colorectal cancer: A systematic review and meta-analysis. Int. J. Colorectal Dis. 37, 541\u2013551. https:\/\/doi.org\/10.1007\/s00384-022-04105-x (2022).","journal-title":"Int. J. Colorectal Dis."},{"key":"78932_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1470-2045(18)30903-3","volume":"20","author":"CJ Bright","year":"2019","unstructured":"Bright, C. J. et al. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (teenage and young adult Cancer Survivor Study): A population-based, cohort study. Lancet Oncol. 20, 531\u2013545. https:\/\/doi.org\/10.1016\/S1470-2045(18)30903-3 (2019).","journal-title":"Lancet Oncol."},{"key":"78932_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3322\/caac.21286","volume":"65","author":"K El-Shami","year":"2015","unstructured":"El-Shami, K. et al. American Cancer Society Colorectal Cancer Survivorship Care Guidelines. CA Cancer J. Clin. 65, 428\u2013455. https:\/\/doi.org\/10.3322\/caac.21286 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"78932_CR9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1089\/thy.2007.0171","volume":"17","author":"S Subramanian","year":"2007","unstructured":"Subramanian, S. et al. Second primary malignancy risk in thyroid cancer survivors: A systematic review and meta-analysis. Thyroid. 17, 1277\u20131288. https:\/\/doi.org\/10.1089\/thy.2007.0171 (2007).","journal-title":"Thyroid"},{"doi-asserted-by":"publisher","unstructured":"Chuang, S. C. et al. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett. 238: 42\u201352. https:\/\/doi.org\/10.1016\/j.canlet.2005.06.015(2006).","key":"78932_CR10","DOI":"10.1016\/j.canlet.2005.06.015(2006"},{"key":"78932_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/EJE-21-1208","volume":"186","author":"M Kim","year":"2022","unstructured":"Kim, M. et al. Risk factors for second primary malignancies following thyroid cancer: A nationwide cohort study. Eur. J. Endocrinol. 186, 561\u2013571. https:\/\/doi.org\/10.1530\/EJE-21-1208 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"78932_CR12","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/cas.12433","volume":"105","author":"M Utada","year":"2014","unstructured":"Utada, M., Ohno, Y., Hori, M. & Soda, M. Incidence of multiple primary cancers and interval between first and second primary cancers. Cancer Sci. 105, 890\u2013896. https:\/\/doi.org\/10.1111\/cas.12433 (2014).","journal-title":"Cancer Sci."},{"key":"78932_CR13","doi-asserted-by":"publisher","first-page":"16240","DOI":"10.3390\/ijms140816240","volume":"14","author":"AR Brown","year":"2013","unstructured":"Brown, A. R., Simmen, R. C. & Simmen, F. A. The role of thyroid hormone signaling in the prevention of digestive system cancers. Int. J. Mol. Sci. 14, 16240\u201316257. https:\/\/doi.org\/10.3390\/ijms140816240 (2013).","journal-title":"Int. J. Mol. Sci."},{"doi-asserted-by":"publisher","unstructured":"Song, J. H. et al. Secondary Primary Cancer after Primary Gastric Cancer: Literature Review and Big Data Analysis Using the Health Insurance Review and Assessment Service (HIRA) Database of Republic of Korea. Cancers (Basel). 14. (2022). https:\/\/doi.org\/10.3390\/cancers14246165","key":"78932_CR14","DOI":"10.3390\/cancers14246165"},{"key":"78932_CR15","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1002\/cam4.4193","volume":"10","author":"E Crocetti","year":"2021","unstructured":"Crocetti, E. et al. Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998\u20132012. Cancer Med. 10, 6855\u20136867. https:\/\/doi.org\/10.1002\/cam4.4193 (2021).","journal-title":"Cancer Med."},{"key":"78932_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2011.01273.x","author":"G Zhu","year":"2012","unstructured":"Zhu, G. et al. Risk of second primary cancer after treatment for esophageal cancer: A pooled analysis of nine cancer registries. Dis. Esophagus. https:\/\/doi.org\/10.1111\/j.1442-2050.2011.01273.x (2012). 25: 505\u2009\u2013\u200911.","journal-title":"Dis. Esophagus"},{"key":"78932_CR17","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.21873\/anticanres.16879","volume":"36","author":"BK Shah","year":"2016","unstructured":"Shah, B. K., Kandel, P. & Khanal, A. Second primary malignancies in Hepatocellular Cancer - A US Population-based study. Anticancer Res. 36, 3511\u20133514. https:\/\/doi.org\/10.21873\/anticanres.16879 (2016).","journal-title":"Anticancer Res."},{"key":"78932_CR18","doi-asserted-by":"publisher","first-page":"101664","DOI":"10.1016\/j.canep.2019.101664","volume":"64","author":"SJ Schonfeld","year":"2020","unstructured":"Schonfeld, S. J., Morton, L. M., de Berrington, A., Curtis, R. E. & Kitahara, C. M. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000\u20132015. Cancer Epidemiol. 64, 101664. https:\/\/doi.org\/10.1016\/j.canep.2019.101664 (2020).","journal-title":"Cancer Epidemiol."},{"key":"78932_CR19","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1038\/s41598-024-56408-4","volume":"14","author":"LY Jin","year":"2024","unstructured":"Jin, L. Y., Su, X. Y., Li, W. J., Wu, J. & Zhang, H. Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma. Sci. Rep. 14, 5766. https:\/\/doi.org\/10.1038\/s41598-024-56408-4 (2024).","journal-title":"Sci. Rep."},{"key":"78932_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","volume":"4","author":"CC Murphy","year":"2018","unstructured":"Murphy, C. C., Gerber, D. E. & Pruitt, S. L. Prevalence of prior Cancer among persons newly diagnosed with Cancer: An initial report from the Surveillance, Epidemiology, and end results program. JAMA Oncol. 4, 832\u2013836. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3605 (2018).","journal-title":"JAMA Oncol."},{"issue":"1","key":"78932_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ccr3.3492","volume":"9","author":"D Kehagias","year":"2020","unstructured":"Kehagias, D., Kostopoulou, E., Ravazoula, P. & Panagopoulos, K. Thyroid angiosarcoma (TAS) - a rare diagnosis not to be missed. Clin. Case Rep. 9 (1), 173\u2013176. https:\/\/doi.org\/10.1002\/ccr3.3492 (2020).","journal-title":"Clin. Case Rep."},{"key":"78932_CR22","first-page":"801","volume":"36","author":"HT Lynch","year":"1999","unstructured":"Lynch, H. T. & de la Chapelle, A. Genetic susceptibility to non-polyposis colorectal cancer. J. Med. Genet. 36, 801\u2013818 (1999).","journal-title":"J. Med. Genet."},{"key":"78932_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran, K. et al. Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5\u00b724 million UK adults. Lancet. 384, 755\u2013765. https:\/\/doi.org\/10.1016\/S0140-6736(14)60892-8 (2014).","journal-title":"Lancet"},{"key":"78932_CR24","first-page":"1727","volume":"63","author":"BJ Braakhuis","year":"2003","unstructured":"Braakhuis, B. J., Tabor, M. P., Kummer, J. A., Leemans, C. R. & Brakenhoff, R. H. A genetic explanation of Slaughter\u2019s concept of field cancerization: Evidence and clinical implications. Cancer Res. 63, 1727\u20131730 (2003).","journal-title":"Cancer Res."},{"key":"78932_CR25","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/jnci\/djs351","volume":"104","author":"AK Win","year":"2012","unstructured":"Win, A. K. et al. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J. Natl. Cancer Inst. 104, 1363\u20131372. https:\/\/doi.org\/10.1093\/jnci\/djs351 (2012).","journal-title":"J. Natl. Cancer Inst."},{"key":"78932_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1200\/JCO.2005.02.7235","volume":"24","author":"M Bassal","year":"2006","unstructured":"Bassal, M. et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 24, 476\u2013483. https:\/\/doi.org\/10.1200\/JCO.2005.02.7235 (2006).","journal-title":"J. Clin. Oncol."},{"key":"78932_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/thy.2008.0392","volume":"19","author":"AM Sawka","year":"2009","unstructured":"Sawka, A. M. et al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: A systematic review and meta-analysis. Thyroid. 19, 451\u2013457. https:\/\/doi.org\/10.1089\/thy.2008.0392 (2009).","journal-title":"Thyroid"},{"key":"78932_CR28","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1002\/ijc.33116","volume":"147","author":"V Cappagli","year":"2020","unstructured":"Cappagli, V. et al. Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence? Int. J. Cancer. 147, 2838\u20132846. https:\/\/doi.org\/10.1002\/ijc.33116 (2020).","journal-title":"Int. J. Cancer"},{"key":"78932_CR29","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1007\/s00259-022-05779-9","volume":"49","author":"S Kim","year":"2022","unstructured":"Kim, S. et al. Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics. Eur. J. Nucl. Med. Mol. Imaging. 49, 3547\u20133556. https:\/\/doi.org\/10.1007\/s00259-022-05779-9 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"doi-asserted-by":"publisher","unstructured":"Mulita, F. et al. Cancer rate of Bethesda category II thyroid nodules. Med. Glas (Zenica). 19(1). https:\/\/doi.org\/10.17392\/1413-21 (2022).","key":"78932_CR30","DOI":"10.17392\/1413-21"},{"issue":"2","key":"78932_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5603\/EP.a2021.0018","volume":"72","author":"F Mulita","year":"2021","unstructured":"Mulita, F. et al. Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS\/FLUS). Endokrynol Pol. 72 (2), 143\u2013144. https:\/\/doi.org\/10.5603\/EP.a2021.0018 (2021).","journal-title":"Endokrynol Pol."},{"issue":"5","key":"78932_CR32","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/0360-3016(90)90249-j","volume":"19","author":"LE Holm","year":"1990","unstructured":"Holm, L. E. Cancer occurring after radiotherapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 19 (5), 1303\u20131308. https:\/\/doi.org\/10.1016\/0360-3016(90)90249-j (1990).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"doi-asserted-by":"publisher","unstructured":"Yuan, Y. et al. Risk of second primary thyroid cancer in cancer survivors. Sci Rep. 30;14(1):12478. (2024). https:\/\/doi.org\/10.1038\/s41598-024-63155-z","key":"78932_CR33","DOI":"10.1038\/s41598-024-63155-z"},{"key":"78932_CR34","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/cncr.30164","volume":"122","author":"N Donin","year":"2016","unstructured":"Donin, N. et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 122, 3075\u20133086. https:\/\/doi.org\/10.1002\/cncr.30164 (2016).","journal-title":"Cancer"},{"key":"78932_CR35","doi-asserted-by":"publisher","first-page":"102218","DOI":"10.1016\/j.canep.2022.102218","volume":"80","author":"H Kudo","year":"2022","unstructured":"Kudo, H. et al. Do prognoses of patients with second primary cancers differ from those of patients with no prior cancer? A population-based study. Cancer Epidemiol. 80, 102218. https:\/\/doi.org\/10.1016\/j.canep.2022.102218 (2022).","journal-title":"Cancer Epidemiol."},{"key":"78932_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/1471-2407-13-394","volume":"13","author":"C Kim","year":"2013","unstructured":"Kim, C. et al. Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer. BMC Cancer. 13, 394. https:\/\/doi.org\/10.1186\/1471-2407-13-394(2013).","journal-title":"BMC Cancer"},{"key":"78932_CR37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/cam4.3722","volume":"10","author":"X Bian","year":"2021","unstructured":"Bian, X. et al. The impact of a prior malignancy on outcomes in gastric cancer patients. Cancer Med. 10, 1457\u20131470. https:\/\/doi.org\/10.1002\/cam4.3722 (2021).","journal-title":"Cancer Med."},{"key":"78932_CR38","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.21037\/jtd-23-1881","volume":"16","author":"JH Leng","year":"2024","unstructured":"Leng, J. H., Qiu, H. R., Huang, Q. Z., Zhang, J. Q. & Zhou, H. Y. Recommendations for broadening eligibility criteria in esophagus cancer clinical trials: the mortality disparity of esophagus cancer as a first or second primary malignancy. J. Thorac. Dis. 16, 3882\u20133896. https:\/\/doi.org\/10.21037\/jtd-23-1881 (2024).","journal-title":"J. Thorac. Dis."},{"doi-asserted-by":"publisher","unstructured":"He, C. B., Zhang, Y., Cai, Z. Y. & Lin, X. J. Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: A propensity score analysis. 19: 509. (2019). https:\/\/doi.org\/10.1186\/s12885-019-5744-8","key":"78932_CR39","DOI":"10.1186\/s12885-019-5744-8"},{"key":"78932_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/bjc.2017.27","volume":"116","author":"SL Pruitt","year":"2017","unstructured":"Pruitt, S. L., Laccetti, A. L., Xuan, L., Halm, E. A. & Gerber, D. E. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer. Br. J. Cancer. 116, 717\u2013725. https:\/\/doi.org\/10.1038\/bjc.2017.27 (2017).","journal-title":"Br. J. Cancer"},{"key":"78932_CR41","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1038\/s41598-023-32635-z","volume":"13","author":"J He","year":"2023","unstructured":"He, J., Wang, Y., Chen, X. M., Chen, W. & Zhou, J. Y. Value of thyroid cancer history in the prognosis of pancreatic cancer: A SEER population-based study. Sci. Rep. 13, 5771. https:\/\/doi.org\/10.1038\/s41598-023-32635-z (2023).","journal-title":"Sci. Rep."},{"key":"78932_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fpubh.2014.00239","volume":"2","author":"E Veach","year":"2014","unstructured":"Veach, E. et al. Race matters: analyzing the relationship between Colorectal Cancer Mortality Rates and various factors within respective racial groups. Front. Public. Health. 2, 239. https:\/\/doi.org\/10.3389\/fpubh.2014.00239 (2014).","journal-title":"Front. Public. Health"},{"key":"78932_CR43","doi-asserted-by":"publisher","first-page":"14015","DOI":"10.1007\/s00432-023-05233-9","volume":"149","author":"Q Du","year":"2023","unstructured":"Du, Q., Zheng, Z. Y., Wang, Y., Yang, L. & Zhou, Z. G. Genetically predicted thyroid function and risk of colorectal cancer: A bidirectional mendelian randomization study. J. Cancer Res. Clin. Oncol. 149, 14015\u201314024. https:\/\/doi.org\/10.1007\/s00432-023-05233-9 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"78932_CR44","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/cncr.28617","volume":"120","author":"AA Aizer","year":"2014","unstructured":"Aizer, A. A. et al. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer. 120, 1532\u20131539. https:\/\/doi.org\/10.1002\/cncr.28617 (2014).","journal-title":"Cancer"},{"key":"78932_CR45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3322\/caac.21718","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto, A. N., Miller, K. D., Tossas, K. Y., Winn, R. A. & Jemal, A. Siegel, R. L. Cancer statistics for African American\/Black people 2022. CA Cancer J. Clin. 72, 202\u2013229. https:\/\/doi.org\/10.3322\/caac.21718 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"78932_CR46","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.clinre.2021.101709","volume":"45","author":"A Lapeyre-Prost","year":"2021","unstructured":"Lapeyre-Prost, A. et al. Chemotherapy use in end-of-life digestive cancer patients: A retrospective AGEO observational study. Clin. Res. Hepatol. Gastroenterol. 45, 101709. https:\/\/doi.org\/10.1016\/j.clinre.2021.101709 (2021).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"78932_CR47","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s11864-023-01115-x","volume":"24","author":"T Geyer","year":"2023","unstructured":"Geyer, T. et al. Systemic Anticancer Treatment Near the end of life: A narrative literature review. Curr. Treat. Options Oncol. 24, 1328\u20131350. https:\/\/doi.org\/10.1007\/s11864-023-01115-x (2023).","journal-title":"Curr. Treat. Options Oncol."},{"key":"78932_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1634\/theoncologist.2016-0013","volume":"22","author":"J Sheng","year":"2017","unstructured":"Sheng, J. et al. Chemotherapy near the end of life for Chinese patients with solid malignancies. Oncologist. 22, 53\u201360. https:\/\/doi.org\/10.1634\/theoncologist.2016-0013 (2017).","journal-title":"Oncologist"},{"key":"78932_CR49","doi-asserted-by":"publisher","first-page":"1379410","DOI":"10.3389\/fsurg.2024.1379410","volume":"11","author":"GI Verras","year":"2024","unstructured":"Verras, G. I. & Mulita, F. Butyrylcholinesterase levels correlate with surgical site infection risk and severity after colorectal surgery: A prospective single-center study. Front. Surg. 11, 1379410. https:\/\/doi.org\/10.3389\/fsurg.2024.1379410 (2024).","journal-title":"Front. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78932-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78932-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78932-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T01:09:21Z","timestamp":1731546561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78932-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78932"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78932-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27892"}}